Simrat Randhawa

DNTH

Simrat Randhawa serves as officer: EVP, Head of R&D at Dianthus Therapeutics, Inc. (DNTH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$52.8K

Total Sells

2 trades

$10.14M

Net Position

Net Seller

$10.08M

Companies Traded

DNTH

Active Period

Sep 2023 – Mar 2026

3 total trades

Most Recent

Sell DNTH

Mar 13, 2026 · $2.76M

Simrat Randhawa's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

1 · $52.8K

Sells

2 · $10.14M

Total Shares Bought

4,000

Total Shares Sold

230,368

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 13, 2026	Sell	33,830	$81.48	$2.76M	0
Nov 13, 2025	Sell	196,538	$37.55	$7.38M	0
Sep 25, 2023	Buy	4,000	$13.20	$52.8K	4,000

Related Insiders

CARR EDWARD

officer: CHIEF ACCOUNTING OFFICER

DNTHSell · Mar 13, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Mar 13, 2026

Ryan Savitz

CFO & CBO

DNTHSell · Dec 4, 2025

Explore More Insider Trading Data

DNTH Insider Trading Activity

View all insider trades at Dianthus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity